Controlled MAP in the Brain Injury Patient (COMAT Study)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
In brain injury patients, the maintenance of MAP within a very narrow range is desired to avoid complications related to hypoperfusion (undertreatment) or hypertension (over treatment). However, the MAP needed to reach can vary over time based on intracranial pressure. Additionally, it is well know that the nurses in the Intensive care unit managed multiple patients simultaneously and cannot dedicate 100% of his‐her time to adjust drugs infusions. Using a novel automated system can overcome this issue and may lead to more time in MAP target (+/‐ 5mmHg) than the traditional management. After initial rescuscitation of the patients, patients in both groups will have the same baseline maintenance fluid administration of 1‐2 ml/kg/h of crystalloid solution and additionnal fluid boluses administered following the EV1000 monitoring device. The only difference will be the management of vasopressor titration (manual by nurses vs automated via a closed‐loop system)
Epistemonikos ID: faa18211cb7c6edf79027464115fdce59751fc5a
First added on: May 22, 2024